Depo Provera: The Food and Drug Administration approved a label change on Friday for Pfizer’s birth control injection, Depo-Provera, alerting patients to the risk of meningioma, a tumor that develops ...

An injectable contraceptive is under development in India, and U.S. companies are pursuing their own versions.

Researchers are testing male contraceptive pills, gels, and injections, but safety, pregnancy prevention, and reversibility ...

Conversations around women’s health and pharmaceutical accountability are becoming far more urgent across the nation as lawsuits tied to the Depo-Provera birth control shot continue to grow. What ...

The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients to a possible risk for a type of brain ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Contraception is often used to prevent pregnancies and manage menstrual ...

About 60 percent of American women of reproductive age are using a contraceptive method. More than 25 percent of them are using the pill. What about the men? For decades, researchers have been working ...

DMPA is available in two injectable forms: an intramuscular injection, marketed under the name Depo Provera, that can only be administered by a provider, and one that is injected just under the skin.

In June 2026, Pfizer and the lawyers representing women who filed lawsuits involving the Depo-Provera birth control shot told a federal court they had reached a global settlement agreement. This is ...

Pfizer’s battle over the safety label for its birth control injection has finally come to a close. The pharma giant announced that the Food and Drug Administration approved its new safety warning ...

For millions of American romantic partners who aren't currently in the midst of actively trying to conceive a child together, or countless Americans who are single, the entire category of "birth ...

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...